$OPTR OPTIMER PHARMACEUTICALS INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OPTIMER PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in OPTIMER PHARMACEUTICALS INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
OPTIMER PHARMACEUTICALS INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ALTIG ANTHONY E | Director | 20,000 | 0 | Jan 03 2013 | |||
| ALTIG ANTHONY E | Director | 12,500 | 0 | Jun 20 2012 | |||
| ALTIG ANTHONY E | Director | 0 | 0 | Oct 25 2013 | |||
| ALTIG ANTHONY E | Director | 0 | 0 | Dec 03 2010 | |||
| ALTIG ANTHONY E | Director | 0 | 0 | Dec 06 2007 | |||
| AMPER LINDA E | SVP, Human Resources | 0 | 0 | Jan 27 2011 | |||
| AMPER LINDA E | SVP, Human Resources | 0 | 0 | Feb 09 2012 | |||
| AMPER LINDA E | SVP, Human Resources | 0 | 0 | Oct 28 2013 | |||
| AUERBACH MARK | Director | 17,500 | 0 | Jan 03 2013 | |||
| AUERBACH MARK | Director | 0 | 0 | Dec 03 2010 | |||
| AUERBACH MARK | Director | 7,500 | 0 | Jan 03 2012 | |||
| AUERBACH MARK | Director | 10,000 | 0 | Jun 20 2012 | |||
| AUERBACH MARK | Director | 0 | 0 | Oct 28 2013 | |||
| CHANG JOSEPH Y | Director | 94,806 | 0 | Sep 14 2007 | |||
| CHANG JOSEPH Y | Director | 0 | 0 | Dec 03 2010 | |||
| CHANG JOSEPH Y | Director | 109,806 | 0 | Jan 03 2013 | |||
| CHANG JOSEPH Y | Director | 99,806 | 0 | Jan 03 2012 | |||
| CHANG JOSEPH Y | Director | 102,306 | 0 | Jun 20 2012 | |||
| CHANG JOSEPH Y | Director | 0 | 0 | Oct 28 2013 | |||
| Chang Michael N | President, CEO | 0 | 0 | Apr 02 2007 | |||
| Chang Michael N | Director | 483,256 | 0 | Jan 03 2012 | |||
| Chang Michael N | Director | 0 | 0 | Oct 28 2013 | |||
| Che Tessie M | Senior VP, Corporate Affairs | 0 | 0 | Apr 02 2007 | |||
| Che Tessie M | COO and SVP | 483,256 | 0 | Jan 03 2012 | |||
| Chow Joseph | Director | 594,859 | 0 | Feb 14 2007 | |||
| Chow Joseph | Director | 2,500 | 0 | Sep 14 2007 | |||
| EDELMAN JOSEPH | 10% Owner | 113,442 | 0 | Jul 25 2008 | |||
| Frapaise Francois-Xavier | Chief Scientific Officer | 4,211 | 0 | Nov 16 2010 | |||
| Gorbach MD Sherwood | Chief Scientific Officer, SVP | 42,219 | 0 | Aug 14 2012 | |||
| Gorbach MD Sherwood | Chief Scientific Officer, SVP | 0 | 0 | Feb 28 2013 | |||
| Gorbach MD Sherwood | SVP, Chief Scientific Officer | 0 | 0 | Oct 28 2013 | |||
| GREBOW PETER E | Director | 0 | 0 | Feb 23 2009 | |||
| GREBOW PETER E | Director | 0 | 0 | Dec 03 2010 | |||
| GREBOW PETER E | Director | 15,000 | 0 | Jan 03 2013 | |||
| GREBOW PETER E | Director | 7,500 | 0 | Jun 20 2012 | |||
| GREBOW PETER E | Director | 0 | 0 | Oct 28 2013 | |||
| Hartman Kurt M | General Counsel, SVP | 3,500 | 0 | Aug 14 2012 | |||
| Lee Howard | Director | 1,265,619 | 0 | Feb 14 2007 | |||
| Lee Howard | Director | 2,500 | 0 | Sep 14 2007 | |||
| LICHTINGER PEDRO | CEO and President | 93,078 | 0 | May 17 2012 | |||
| LICHTINGER PEDRO | CEO and President | 90,893 | 0 | Feb 09 2012 | |||
| LICHTINGER PEDRO | CEO and President | 24,720 | 0 | May 17 2011 | |||
| LICHTINGER PEDRO | CEO and President | 44,720 | 0 | Jun 01 2011 | |||
| LICHTINGER PEDRO | CEO and President | 104,078 | 0 | Nov 19 2012 | |||
| LICHTINGER PEDRO | 104,078 | 0 | Apr 10 2013 | ||||
| MCKINNELL HENRY A | Director | 0 | 0 | Jan 11 2011 | |||
| MCKINNELL HENRY A | Director | 35,000 | 0 | Jan 03 2013 | |||
| MCKINNELL HENRY A | Director | 25,000 | 0 | Jun 20 2012 | |||
| MCKINNELL HENRY A | CEO and Chairman of the Board | 0 | 0 | Feb 28 2013 | |||
| MCKINNELL HENRY A | CEO and Chairman of the Board | 0 | 0 | Oct 28 2013 | |||
| Muenchbach Martin | Director | 1,025,624 | 0 | Feb 14 2007 | |||
| Muenchbach Martin | Director | 2,500 | 0 | Dec 06 2007 | |||
| Newman Stephen L | Director | 7,500 | 0 | Jan 03 2013 | |||
| Newman Stephen L | Director | 0 | 0 | Oct 28 2013 | |||
| Papaz Gregory E. | SVP, Commercial Operations | 2,592 | 0 | May 17 2012 | |||
| Par Pharmacuetical, Inc. | 10% Owner | 1,257,656 | 0 | Feb 23 2007 | |||
| Par Pharmacuetical, Inc. | 10% Owner | 2,307,655 | 0 | Feb 14 2007 | |||
| Poulos Kevin P | VP, Marketing and Sales | 600 | 0 | Apr 02 2007 | |||
| Poulos Kevin P | Chief Commercial Officer | 7,547 | 0 | May 17 2010 | |||
| Prunty John D | CFO, VP Finance & Secretary | 0 | 0 | Apr 02 2007 | |||
| Prunty John D | CFO | 1,000 | 0 | Nov 19 2007 | |||
| Prunty John D | CFO and SVP, Finance | 12,985 | 0 | Feb 09 2012 | |||
| Schaum Meredith | Gen Counsel and Chief Comp Off | 0 | 0 | Oct 28 2013 | |||
| SCHREIBER ALAIN | Director | 811,998 | 0 | Jan 12 2010 | |||
| SCHREIBER ALAIN | Director | 48,001 | 0 | Feb 14 2007 | |||
| SCHREIBER ALAIN | Director | 2,500 | 0 | Sep 14 2007 | |||
| Shue Youe Kong | VP, Clinical Development | 5,538 | 0 | Apr 02 2007 | |||
| Shue Youe Kong | VP, Clinical Development | 94,230 | 0 | Feb 09 2012 | |||
| Sirota Eric | Chief Operating Officer | 0 | 0 | Oct 28 2013 | |||
| Webster Stephen W | CFO | 25,000 | 0 | Jul 02 2012 | |||
| Webster Stephen W | CFO | 0 | 0 | Feb 28 2013 | |||
| Webster Stephen W | Chief Financial Officer | 0 | 0 | Oct 28 2013 | |||
| ZERBE ROBERT L MD | Director | 0 | 0 | Dec 03 2010 | |||
| ZERBE ROBERT L MD | Director | 5,000 | 0 | Jan 03 2012 | |||
| ZERBE ROBERT L MD | Director | 7,500 | 0 | Jun 25 2012 | |||
| ZERBE ROBERT L MD | Director | 15,000 | 0 | Jan 03 2013 | |||
| ZERBE ROBERT L MD | Director | 0 | 0 | Oct 28 2013 |